Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renegade BioConsulting is a private life sciences consulting company focused on serving biotech, pharma, and medtech clients rather than developing its own therapeutic pipeline. The firm provides executive advisory services spanning international expansion, corporate communications, fundraising support, and commercialization strategy. Available public profiles describe it as a global consultancy founded by Doug Nissinoff and operating as a for-profit business. Based on the available evidence, Renegade BioConsulting appears to function as a specialist strategic and business-development advisor to healthcare companies, not as a drug developer, platform biotech, CRO, or manufacturer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renegade BioConsulting.